Valuation: Genpharmasec Limited

Market Cap 59Cr 61.63L 54.76L 51.11L 46.58L 87.86L 88.68L 6.19Cr 2.4Cr 30Cr 2.31Cr 2.26Cr 97Cr P/E 2025
94.5x
P/E 2026 26.9x
Enterprise Value 84Cr 87.5L 77.75L 72.57L 66.14L 1.25Cr 1.26Cr 8.78Cr 3.4Cr 43Cr 3.29Cr 3.21Cr 138.01Cr EV / Sales 2025
2.96x
EV / Sales 2026 0.49x
Free-Float
54.91%
Yield 2025 *
-
Yield 2026 -
1 day-4.46%
1 week-6.96%
Current month-4.46%
1 month-13.71%
3 months-6.14%
Current year-18.32%
1 week 1.05
Extreme 1.05
1.17
1 month 1.05
Extreme 1.05
1.33
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
1.91
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 01/11/2022
Compliance Officer - 27/03/2024
Director TitleAgeSince
Director/Board Member 57 02/01/2019
Director/Board Member 58 02/01/2019
Director/Board Member - 01/11/2022
Change 5-day change 1-year change 3-year change Capi.($)
-4.46%-6.96%-43.39%-73.05% 61.63L
+0.84%-3.74%-26.69%+1.85% 17TCr
-0.07%-2.55%-9.53%+11.07% 11TCr
+0.90%+1.13%-24.83%+0.58% 11TCr
-1.24%-0.76%-49.04%-12.75% 7.39TCr
-0.24%+0.69%+0.16%+72.58% 5.9TCr
-0.86%+2.96%+13.57%+59.50% 5.13TCr
-0.71%-3.82%-7.72%-31.41% 4.82TCr
+0.12%-0.17%-18.21%+20.29% 4.08TCr
-1.01%-1.45%+28.48%-9.72% 3.22TCr
Average -0.67%-1.22%-13.72%+3.89% 6.9TCr
Weighted average by Cap. +0.03%-1.30%-16.36%+10.13%

Financials

2025 2026
Net sales 34Cr 35.08L 31.17L 29.09L 26.51L 50.01L 50.47L 3.52Cr 1.36Cr 17Cr 1.32Cr 1.29Cr 55Cr 139.94Cr 1.46Cr 1.29Cr 1.21Cr 1.1Cr 2.08Cr 2.09Cr 15Cr 5.66Cr 72Cr 5.47Cr 5.35Cr 229.59Cr
Net income 1.23Cr 1L 1L 1L 96.8T 2L 2L 12.85L 5L 62.94L 5L 5L 2.02Cr 1.6Cr 2L 1L 1L 1L 2L 2L 16.74L 6L 81.98L 6L 6L 2.63Cr
Net Debt -94.03L -97.81T -86.91T -81.11T -73.93T -1L -1L -10L -4L -48.07L -4L -4L -1.54Cr 25Cr 25.87L 22.99L 21.46L 19.56L 36.88L 37.23L 2.6Cr 1.01Cr 13Cr 97.14L 95.03L 41Cr
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
13
Date Price Change Volume
01/26/01 ₹1.070 -4.46% 2,99,160
30/26/30 ₹1.120 0.00% 1,58,401
29/26/29 ₹1.120 -0.88% 2,21,930
28/26/28 ₹1.130 -1.74% 1,33,896
25/26/25 ₹1.150 +2.68% 3,26,801
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock